Universal Biosensors’ (UBI) core capabilities are product development and manufacturing. UBI’s business model has previously been to commercialise products on its platform technology by partnering with market leaders:

UBI’s first global strategic partnership was established with LifeScan (a Johnson & Johnson company), soon after the company was founded in 2001.

In September 2012, UBI signed a long term supply and manufacturing agreement with Siemens Healthcare Diagnostics to manufacture several test strips currently being jointly developed for the point-of-care coagulation market.

UBI continues to seek out strategic partnerships with global market leaders as well as engaging in mutually beneficial relationships with universities, other like-minded businesses and government funded research bodies.